Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pseudomonas syringae pv. tomato Selenide, water dikinase (selD) CSB-YP768507FGP
CSB-EP768507FGP
CSB-BP768507FGP
CSB-MP768507FGP
CSB-EP768507FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato GTP cyclohydrolase-2 (ribA) CSB-YP768508FGP
CSB-EP768508FGP
CSB-BP768508FGP
CSB-MP768508FGP
CSB-EP768508FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 30S ribosomal protein S4 (rpsD) CSB-YP768509FGP
CSB-EP768509FGP
CSB-BP768509FGP
CSB-MP768509FGP
CSB-EP768509FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 50S ribosomal protein L6 (rplF) CSB-YP768510FGP
CSB-EP768510FGP
CSB-BP768510FGP
CSB-MP768510FGP
CSB-EP768510FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 30S ribosomal protein S17 (rpsQ) CSB-YP768511FGP
CSB-EP768511FGP
CSB-BP768511FGP
CSB-MP768511FGP
CSB-EP768511FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 30S ribosomal protein S19 (rpsS) CSB-YP768512FGP
CSB-EP768512FGP
CSB-BP768512FGP
CSB-MP768512FGP
CSB-EP768512FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 50S ribosomal protein L1 (rplA) CSB-YP768513FGP
CSB-EP768513FGP
CSB-BP768513FGP
CSB-MP768513FGP
CSB-EP768513FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP768514FGP
CSB-EP768514FGP
CSB-BP768514FGP
CSB-MP768514FGP
CSB-EP768514FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Thiosulfate sulfurtransferase glpE (glpE) CSB-YP768515FGP
CSB-EP768515FGP
CSB-BP768515FGP
CSB-MP768515FGP
CSB-EP768515FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Pyrroloquinoline-quinone synthase (pqqC) CSB-YP768516FGP
CSB-EP768516FGP
CSB-BP768516FGP
CSB-MP768516FGP
CSB-EP768516FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato HTH-type transcriptional regulator BetI (betI) CSB-YP768517FGP
CSB-EP768517FGP
CSB-BP768517FGP
CSB-MP768517FGP
CSB-EP768517FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Peptide methionine sulfoxide reductase MsrA (msrA) CSB-YP768518FGP
CSB-EP768518FGP
CSB-BP768518FGP
CSB-MP768518FGP
CSB-EP768518FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Sulfate/thiosulfate import ATP-binding protein CysA (cysA) CSB-YP768519FGP
CSB-EP768519FGP
CSB-BP768519FGP
CSB-MP768519FGP
CSB-EP768519FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Tyrosine recombinase XerC (xerC) CSB-YP768520FGP
CSB-EP768520FGP
CSB-BP768520FGP
CSB-MP768520FGP
CSB-EP768520FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Peptide deformylase 1 (def1) CSB-YP768521FGP
CSB-EP768521FGP
CSB-BP768521FGP
CSB-MP768521FGP
CSB-EP768521FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 50S ribosomal protein L33 (rpmG) CSB-YP768522FGP
CSB-EP768522FGP
CSB-BP768522FGP
CSB-MP768522FGP
CSB-EP768522FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Acetylglutamate kinase (argB) CSB-YP768523FGP
CSB-EP768523FGP
CSB-BP768523FGP
CSB-MP768523FGP
CSB-EP768523FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida ATP synthase subunit c (atpE), partial CSB-YP768524FGB1
CSB-EP768524FGB1
CSB-BP768524FGB1
CSB-MP768524FGB1
CSB-EP768524FGB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida NAD-dependent protein deacylase (cobB) CSB-YP768525FGB
CSB-EP768525FGB
CSB-BP768525FGB
CSB-MP768525FGB
CSB-EP768525FGB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP768526FGB
CSB-EP768526FGB
CSB-BP768526FGB
CSB-MP768526FGB
CSB-EP768526FGB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>